sarpogrelate has been researched along with Extravascular Hemolysis in 2 studies
sarpogrelate: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"We evaluate the clinical efficacy of sarpogrelate, an antiplatelet drug that improves red blood cell deformability, to reduce the intravascular hemolysis problems suffered frequently by patients implanted with heart valve prostheses." | 7.70 | Sarpogrelate reduces mechanical hemolysis in patients with heart valve prostheses. ( Kawaguchi, O; Ohara, Y; Takagi, Y; Ueda, Y; Usui, A; Watanabe, T, 2000) |
"We evaluate the clinical efficacy of sarpogrelate, an antiplatelet drug that improves red blood cell deformability, to reduce the intravascular hemolysis problems suffered frequently by patients implanted with heart valve prostheses." | 3.70 | Sarpogrelate reduces mechanical hemolysis in patients with heart valve prostheses. ( Kawaguchi, O; Ohara, Y; Takagi, Y; Ueda, Y; Usui, A; Watanabe, T, 2000) |
"Sarpogrelate has been reported to increase erythrocyte deformability and suppress shear stress-induced hemolysis." | 1.36 | Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study. ( Kawahito, K; Nakamura, K, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, K | 1 |
Kawahito, K | 1 |
Usui, A | 1 |
Takagi, Y | 1 |
Ohara, Y | 1 |
Kawaguchi, O | 1 |
Watanabe, T | 1 |
Ueda, Y | 1 |
2 other studies available for sarpogrelate and Extravascular Hemolysis
Article | Year |
---|---|
Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study.
Topics: Cells, Cultured; Erythrocytes; Hemolysis; Humans; Platelet Aggregation Inhibitors; Serotonin Antagon | 2010 |
Sarpogrelate reduces mechanical hemolysis in patients with heart valve prostheses.
Topics: Adult; Female; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; He | 2000 |